Morgan Stanley Downgrades Adient (ADNT) to Underweight
Tweet
Share
E-mailGet Alerts ADNT Hot Sheet
Price: $18.62 -2.72%
Rating Summary:
10 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
10 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Morgan Stanley analyst Adam Jonas downgraded Adient (NYSE: ADNT) from Overweight to Underweight with a price target of $38.00.
For an analyst ratings summary and ratings history on Adient click here. For more ratings news on Adient click here.
Shares of Adient closed at $46.09 yesterday.
You May Also Be Interested In
- Oppenheimer Downgrades Legend Biotech Corp. (LEGN) to Perform, 'CEO/Partnership/Competition Overhangs to Cap Upside'
- BTIG Downgrades Apogee Therapeutics Inc (APGE) to Neutral
- UBS Downgrades DiaSorin SpA (DIA:IM) (DSRLF) to Sell
Create E-mail Alert Related Categories
Downgrades, Hot DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
